Global Genetic Testing Market Outlook 2022 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 20, 2018--The “Global Genetic Testing Market Outlook 2022” report has been added to ResearchAndMarkets.com’s offering.
Global Genetic Testing Market Outlook 2022 provides a detailed analysis of the genetic testing market. The report also provides an insight regarding the current and future prospective of the market. This report covers the major trends and drivers, and their impact on the market. The report also discusses some of the restraints that can hinder the growth of the market, as well as rising opportunities which can provide new dimensions to the industry.
The advent of genetic tests has revolutionized the molecular diagnostics and cytogenetic industry. It is one of the most rapidly growing segments in molecular diagnostics industry, which helps in delivering customized health services or personalized medicine. The share of genetic testing is incessantly increasing in the market. Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the major factors propelling the genetic testing market.
The segmentation of genetic testing markets has been done in the report on the basis of applications, diseases, and geographical regions.
The company profiles segment in this report is entirely devoted to profiling leading companies of the genetic testing industry including some major players like Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., Hologic, Inc., Cepheid, Agilent Technologies and QIAGEN.
This segment provides you access to the new launched products, recent developments, and strengths and weaknesses of these companies to deliver a clear understanding/view of the competitive landscape. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors.
DriversRising Incidence of Chronic Diseases Growth in Ageing Population Increasing Government Initiatives Rising Investments in Genetic Testing Market Incessant Launch of New Genetic Tests
ChallengesLow Awareness for Genetic Testing in Developing Countries High Cost of Genetic Tests Varying Reimbursement Policies Ethical and Policy Issues
OpportunitiesNext-Generation Sequencing (NGS) Non-Invasive Prenatal Testing (NIPT) Whole Genome Sequencing (WGS) for Cancer Personalized Medicine
TrendsGenetic Testing in Oncology: Gaining Momentum Strong Demand for Pharmacogenomics At-Home DNA Tests or Direct-To-Consumer (DTC) Genetic Tests
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Genetic Testing Overview
4. Industry Overview
5. Global Genetic Testing Market Outlook
6. Global Genetic Testing Market by Application
7. Global Genetic Testing Market by Disease
8. Global Genetic Testing Market by Geography
9. Genetic Testing Regulations
10. Mergers & Acquisitions
11. Company ProfilesAbbott Laboratories Roche Diagnostics Myriad Genetics, Inc. Thermo Fisher Scientific, Inc. Agilent Technologies, Inc. Hologic, Inc. Illumina, Inc. QIAGEN N.V. Cepheid Quest Diagnostics
For more information about this report visit https://www.researchandmarkets.com/research/sljcmx/global_genetic?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180920005554/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS GENETICS RESEARCH SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/20/2018 10:36 AM/DISC: 09/20/2018 10:36 AM